Severine Vermeire

Severine Vermeire is a Professor at the Faculty of Medicine, KU Leuven, affiliated with the Department of Chronic Diseases and Metabolism. She leads translational research in gastrointestinal disorders, focusing on inflammatory bowel diseases (IBD), Crohn's disease, and ulcerative colitis.

• Key research areas: Host-microbiome interactions, fibrosis mechanisms, biomarker discovery, and value-based healthcare
• Active in multinational clinical trials evaluating therapies like mirikizumab and tofacitinib
• Developing predictive tools such as PredictSURE IBD and clinical decision support systems

Her recent work emphasizes precision medicine, including polygenic risk score pipelines and automated endoscopic diagnostics. She contributes to regulatory science through comparative FDA-EMA guidance analysis for IBD drug development.

Teaching focuses on gastrointestinal problem-solving skills and advanced gastroenterology training programs.